Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib and Adriamycin in Retroperitoneal Sarcoma
NCT02587169Phase 2Unknown
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in retroperitoneal liposarcoma (RLS), retroperitoneal leiomyosarcoma (RLMS), chondrosarcoma. Status: unknown.
02
Drugs
nilotinib
03
Conditions
retroperitoneal liposarcoma (RLS)retroperitoneal leiomyosarcoma (RLMS)chondrosarcoma
Beyond the preview
Go deeper on NCT02587169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587169.